![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2018
Vries, Rory D. de; Altenburg, Arwen F.; Nieuwkoop, Nella J.; Bruin, Erwin de; Trierum, Stella E. van; Pronk, Mark R.; Lamers, Mart M.; Richard, Mathilde; Nieuwenhuijse, David F.; Koopmans, Marion P. G.; Kreijtz, Joost H. C. M.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Sutter, Gerd 
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
2017
Altenburg, Arwen F.; Sandt, Carolien E. van de; Li, Bobby W. S.; MacLoughlin, Ronan J.; Fouchier, Ron A. M.; Amerongen, Geert van; Volz, Asisa; Hendriks, Rudi W.; Swart, Rik L. de; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X; Rimmelzwaan, Guus F. und Vries, Rory D. de
(2017):
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.
In: Scientific Reports, Bd. 7, 8580
[PDF, 8MB]
ORCID: https://orcid.org/0000-0001-6143-082X; Rimmelzwaan, Guus F. und Vries, Rory D. de
(2017):
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.
In: Scientific Reports, Bd. 7, 8580
[PDF, 8MB]
2016
Altenburg, Arwen F.; Sandt, Carolien E. van de; Trierum, Stella E. van; Gruyter, Heidi L. M. de de; Run, Peter R. W. A. van; Fouchier, Ron A. M.; Roose, Kenny; Saelens, Xavier; Volz, Asisa; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X; Vries, Rory D. und Rimmelzwaan, Guus F.
(2016):
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8(+) T Cell Activation In Vitro but Not in C57BL/6 Mice.
In: Journal of Virology, Bd. 90, Nr. 22: S. 10209-10219
ORCID: https://orcid.org/0000-0001-6143-082X; Vries, Rory D. und Rimmelzwaan, Guus F.
(2016):
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8(+) T Cell Activation In Vitro but Not in C57BL/6 Mice.
In: Journal of Virology, Bd. 90, Nr. 22: S. 10209-10219
2014
Altenburg, Arwen F.; Kreijtz, Joost H. C. M.; de Vries, Rory D.; Song, Fei; Fux, Robert; Rimmelzwaan, Guus F.; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(Juli 2014):
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.
In: Viruses, Bd. 6, Nr. 7: S. 2735-2761
[PDF, 847kB]
ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(Juli 2014):
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.
In: Viruses, Bd. 6, Nr. 7: S. 2735-2761
[PDF, 847kB]